Shockwave Medical Inc. (NASDAQ:SWAV)

An analysis of the valuation multiples from 2019 to 2023 reveals a transition from high-growth, asset-and-revenue-based valuations toward earnings-based valuations as the company achieved profitability.

Price to Earnings (P/E) and Price to Operating Profit (P/OP)

Valuations based on earnings and operating profit were not recorded until 2022, indicating a shift in the company's financial profile toward profitability. The P/E ratio rose sharply from 32.02 in 2022 to 65.99 in 2023, suggesting an increase in investor expectations for future earnings growth. Similarly, the P/OP ratio saw a moderate increase from 55.72 in 2022 to 61.09 in 2023.

Price to Sales (P/S)

The P/S ratio exhibited significant volatility, peaking at 60.01 in 2020 before entering a consistent downward trend. From 2021 to 2023, the ratio declined from 26.40 to 13.31. This trend suggests that revenue growth accelerated at a faster rate than the stock price, or that the market applied a lower multiple to sales as the company matured.

Price to Book Value (P/BV)

The P/BV ratio increased substantially from 4.78 in 2019 to a peak of 25.89 in 2021. A significant correction occurred in 2022, with the ratio dropping to 13.53, followed by a slight recovery to 14.53 in 2023. This pattern mirrors the volatility seen in the P/S ratio, indicating a period of aggressive valuation expansion followed by a stabilization phase.

Overall, the valuation profile evolved from extreme multiples in 2020 and 2021 toward more stabilized levels by 2023, with the market increasingly focusing on earnings capacity rather than purely on revenue and book value.

A consistent upward trajectory in share price is observed from 2019 through 2023, with the value increasing from 29.00 USD to 259.89 USD. This appreciation in market value coincided with a fundamental transition in the company's profitability profile, moving from net losses to positive earnings per share.

Earnings per Share (EPS) Performance

The company operated at a loss from 2019 to 2021, though the magnitude of the loss narrowed significantly by the end of 2021. A pivot to profitability was achieved in 2022 with an EPS of 5.92 USD. However, a subsequent contraction in earnings occurred in 2023, with EPS declining to 3.94 USD.

Price-to-Earnings (P/E) Ratio Evolution

The P/E ratio was not applicable during the initial three years of the period due to negative earnings. Upon the achievement of profitability in 2022, the P/E ratio was established at 32.02. By December 31, 2023, this ratio expanded to 65.99, representing a significant increase in the valuation multiple.

Valuation Dynamics

An inverse relationship is noted between earnings performance and the valuation multiple between 2022 and 2023. While EPS decreased by approximately 33.4%, the share price continued to rise, leading to a doubling of the P/E ratio. This suggests that market valuation expanded independently of current earnings growth, indicating higher investor expectations for future performance.

A significant transition in financial performance and market valuation is evident between 2019 and 2023. The trajectory is characterized by a shift from operational losses to consistent profitability, accompanied by a substantial and continuous increase in equity valuation.

Share Price Appreciation

A consistent upward trend in the share price is observed, ascending from 29.00 US$ in 2019 to 259.89 US$ by the end of 2023. This represents a significant expansion in market capitalization over the five-year period.

Operational Profitability Transition

Operating profit per share remained negative from 2019 through 2021, narrowing from -1.63 US$ to a near-breakeven point of -0.02 US$ by the end of 2021. A definitive shift to profitability was achieved in 2022 with a value of 3.40 US$, which further improved to 4.25 US$ in 2023.

Price to Operating Profit (P/OP) Analysis

The P/OP ratio was not applicable during the years of operational losses. Upon the attainment of positive operating profit in 2022, the ratio was established at 55.72 and subsequently rose to 61.09 in 2023. The increase in this multiple indicates that the share price grew at a faster rate than the operating profit during this interval, suggesting high investor expectations for future earnings growth.

The valuation profile from 2019 to 2023 reflects a transition from high speculative pricing toward a valuation more closely aligned with fundamental revenue growth. While the share price maintained a consistent upward trajectory throughout the period, the price-to-sales (P/S) ratio exhibited significant volatility followed by a period of sustained compression.

Share Price Appreciation

The share price grew consistently over the five-year period, rising from US$ 29.00 in 2019 to US$ 259.89 in 2023. This represents a substantial increase in market capitalization, indicating sustained investor demand.

Sales per Share Expansion

Revenue generation per share experienced exponential growth, increasing from US$ 1.35 in 2019 to US$ 19.53 in 2023. The most aggressive growth phase occurred between 2020 and 2022, where sales per share increased from US$ 1.95 to US$ 13.42.

Price-to-Sales (P/S) Ratio Dynamics

The P/S ratio peaked at 60.01 in 2020, suggesting a period of extreme valuation premiums. However, a clear downward trend followed, with the ratio declining to 26.40 in 2021, 14.12 in 2022, and finally 13.31 in 2023. This compression indicates that the growth in sales per share significantly outpaced the growth in share price after 2020, effectively "growing into" the valuation and reducing the premium paid per dollar of revenue.

The analysis of valuation metrics from 2019 to 2023 reveals a period of significant market valuation expansion followed by a realignment driven by an increase in net asset value.

Share Price Evolution

A consistent and substantial upward trend is observed in the share price, which climbed from 29.00 US$ in 2019 to 259.89 US$ by 2023. The most aggressive growth phase occurred between 2019 and 2021, establishing a higher valuation baseline for the equity.

Book Value Per Share (BVPS) Trends

BVPS exhibited modest growth from 2019 to 2021, moving from 6.06 US$ to 6.78 US$. A significant inflection point is noted in 2022, where BVPS more than doubled to 14.01 US$, subsequently rising to 17.88 US$ in 2023. This indicates a marked increase in the company's equity base during the latter part of the period.

Price to Book Value (P/BV) Ratio Analysis

The P/BV ratio experienced a sharp escalation, rising from 4.78 in 2019 to a peak of 25.89 in 2021, suggesting that market pricing was driven heavily by growth expectations rather than tangible book value. A correction occurred in 2022, with the ratio dropping to 13.53, primarily due to the substantial increase in BVPS. The ratio remained relatively stable in 2023, closing at 14.53.

The overall trajectory indicates that while the share price continued to rise through 2023, the valuation multiple contracted from its 2021 peak as the company's book value began to catch up with the market price. The transition from a P/BV of 25.89 to approximately 14.53 reflects a shift toward a valuation more supported by the company's balance sheet strength.